Gad Singer

Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma

Gad Singer, Robert F. Oldt, Yoram Cohen et al. · JNCI Journal of the National Cancer Institute · 2003 · 848 citations

Kras Mutations, Braf Codon 599, Tumoral Pathology +14

Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis

Gad Singer, Robert Stöhr, Leslie Cope et al. · The American Journal of Surgical Pathology · 2005 · 406 citations

Mutational Status, Urology, New Model +14

Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma

Gad Singer, Robert J. Kurman, Hsueh‐Wei Chang et al. · American Journal Of Pathology · 2002 · 340 citations · Full text

Diverse Tumorigenic Pathways, Gynecology, Medicine +3

The First Analysis and Clinical Evaluation of Native Breast Tissue Using Differential Phase-Contrast Mammography

Marco Stampanoni, Zhentian Wang, Thomas Thüring et al. · Investigative Radiology · 2011 · 255 citations

How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists

Zsuzsanna Varga, Joachim Diebold, Corina Dommann‐Scherrer et al. · PLoS ONE · 2012 · 224 citations · Full text